Verrica targets European expansion for YCANTH as Phase III programs advance and sales force grows [Seeking Alpha]
JAPAN TOBACCO UNSP/ADR (JAPAY)
NASDAQ:AMEX Investor Relations:
gungho.co.jp/en/ir
Company Research
Source: Seeking Alpha
Jayson Rieger, President and CEO, highlighted several commercial, corporate, scientific, and regulatory milestones, emphasizing, "we've advanced our clinical programs in two of the highest unmet needs in dermatology for future development" and announced a global Phase III program Quick Insights Verrica anticipates strong growth driven by YCANTH's advancing clinical milestones, upcoming EU filings, and expansion to new indications, bolstered by positive regulatory feedback and partnerships like with Torii Pharmaceutical. Q3 results were primarily driven by $10.7 million in Torii milestone and collaboration revenue, alongside $3.6 million in net YCANTH revenue, with cost reductions and changes in product margin impacting overall profitability. Key challenges include seasonality affecting dispensed unit growth, competition from 'watch and wait' approaches, dependency on milestone payments, EU regulatory sequencing, and initial copay assistance investments. More Trending News
Show less
Read more
Impact Snapshot
Event Time:
JAPAY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JAPAY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JAPAY alerts
High impacting JAPAN TOBACCO UNSP/ADR news events
Weekly update
A roundup of the hottest topics
JAPAY
News
- Japan Tob (OTCMKTS:JAPAY) had its "underweight" rating reaffirmed by analysts at Barclays PLC.MarketBeat
- Japan Tobacco Inc (JAPAF) Q3 2025 Earnings Call Highlights: Strong Growth in AOP and Tobacco Volume [Yahoo! Finance]Yahoo! Finance
- Tracking the Evolving Narrative for Japan Tobacco After Dividend Hike and Upgraded Outlook [Yahoo! Finance]Yahoo! Finance
- LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) [Yahoo! Finance]Yahoo! Finance
- LEO Pharma Takes Centre Stage With its Largest-Ever Scientific Programme at EADV 2025 [Yahoo! Finance]Yahoo! Finance